PVSG and WHO bone marrow evaluation in 90 essential thrombocythaemia (ET) patients treated with Peg interferon A2b. Preliminary results

MLA

Gugliotta L, et al. PVSG and WHO Bone Marrow Evaluation in 90 Essential Thrombocythaemia (ET) Patients Treated with Peg Interferon A2b. Preliminary Results. Jan. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..55c4438ec64af9df0b1a59c3f7f04c6c&authtype=sso&custid=ns315887.

APA

Gugliotta L, Bulgarelli S, Tieghi A, Asioli A, Gardini G, Sabattini E, & Franco, V. (2005). PVSG and WHO bone marrow evaluation in 90 essential thrombocythaemia (ET) patients treated with Peg interferon A2b. Preliminary results.

Chicago

Gugliotta L, Bulgarelli S, Tieghi A, Asioli A, Gardini G, Sabattini E, and Vito Franco. 2005. “PVSG and WHO Bone Marrow Evaluation in 90 Essential Thrombocythaemia (ET) Patients Treated with Peg Interferon A2b. Preliminary Results,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3658..55c4438ec64af9df0b1a59c3f7f04c6c&authtype=sso&custid=ns315887.